75987-150 : Uplizna 10 mg/ml Intravenous Injection
NDC: | 75987-150 |
Labeler: | Horizon Therapeutics USA, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Uplizna |
Dosage Form: | Intravenous Injection |
Application #: | BLA761142 |
Rev. Date: |
NDC Package Codes:
- 75987-150-03: 3 VIAL, SINGLE‑DOSE IN 1 CARTON (75987‑150‑03) > 10 ML IN 1 VIAL, SINGLE‑DOSE (75987‑150‑01)
Active Ingredients:
- Inebilizumab
Dosage Strength:
- 10 mg/mL
Pharmaceutical Classes:
- CD19-directed Antibody Interactions [MoA]
- CD19-directed Cytolytic Antibody [EPC]
Related Products:
Based on records with the same trade name.- 72677-551 Uplizna 10 mg/ml Intravenous Injection by Viela Bio, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 75987-145Next: 75989-550 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.